A British startup, Mass Balance, has launched a self-operating laboratory into orbit to study how disease-causing proteins behave in microgravity.The grapefruit-sized apparatus, housed in a Tumbleweed pod, will orbit Earth for months, collecting data on cellular reactions under zero-gravity conditions.

This research aims to address challenges in studying disordered proteins linked to Alzheimer’s, Parkinson’s, and certain cancers, which are difficult to analyze on Earth due to gravitational effects like convection and sedimentation.By leveraging microgravity, scientists hope to improve AI models for predicting protein behavior and drug responses.

The experiment is part of a broader trend of biotech startups developing orbital labs, with Mass Balance focusing on space-based research rather than returning equipment to Earth.

The initiative could revolutionize life sciences by providing unique data for training models like AlphaFold, potentially advancing treatments for age-related diseases.